Foley Hoag Lawyers to Speak at BIO International Convention
Partners Hemmie Chang and Jeffrey Quillen will each present at this global event for the biotechnology industry, now in its 20th year
April 18, 2013
Foley Hoag LLP partners Hemmie Chang and Jeffrey Quillen will lead panels on legal and regulatory issues affecting the biotechnology and pharmaceutical industries at the 2013 BIO International Convention from April 22-25 at McCormick Place in Chicago, IL.Monday, April 22, 3:45-5:00 p.m.
“Can You Reap What You Sow? How the Necessity of Acquiring Early-Stage Assets Can Also Be Win-Win”
Moderator: Hemmie Chang
Business Development Track – Building N427BC
How much is the focus on early-stage assets driven by necessity, or is the opportunity to fill pipelines with external expertise also an attractive opportunity? Can the increased risk be balanced by the increased likelihood of success in the collaboration? How can these deals be structured to realize the synergies each side brings to the table and engender a meaningful commitment by both partners? Is there a formula emerging biotechs can or should follow to attract partners? As many business development groups direct their efforts to identifying early-stage opportunities, this panel will also discuss evolving deal structures which seek to better match risk and reward.Wednesday, April 24, 9:00-10:15 a.m.
“Creating Value with Limited Liability Companies and Asset-Centric Investing”
Moderator: Jeffrey Quillen
Finance Track - Building: N426B
For decades, start-up companies across industries have been organized as corporations. Most investors insisted on this. However, to keep pace with the challenges facing the biotech industry, a handful of entrepreneurs have challenged the old orthodoxy, developing corporate structures that use limited liability companies instead. These new structures provide benefits to investors, management teams and Big BioPharm buyers. This panel will discuss these structures, the problems they solve and when and how they should be used.
Foley Hoag has a longstanding relationship with the Biotechnology Industry Organization (BIO). For the past seven years, the firm has participated in the annual International Convention- one of the largest biotech gatherings in the world - via speaking panels, as an exhibitor and as special event hosts.
On April 23 from 6-9 p.m., Foley Hoag will host a cocktail reception for BIO guests at The Paris Club at 59 West Hubbard Street.
About Foley Hoag LLP
Foley Hoag provides innovative, strategic legal services to public, private and government clients across the globe. We have premier capabilities in the life sciences, healthcare, technology, energy, professional services and private funds fields, and in cross-border disputes. The diverse backgrounds, perspectives and experiences of our lawyers and staff contribute to the exceptional senior level service we deliver to clients ranging from startups to multinational companies to sovereign states. For more information, visit www.foleyhoag.com or follow @FoleyHoag on Twitter.